Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial-Reference-Cited by-同舟云学术

Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial

Published:2021-05 Issue:5 Volume:3 Page:e337-e346
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Pratt Arthur G,Siebert Stefan,Cole Michael,Stocken Deborah D,Yap Christina,Kelly Stephen,Shaikh Muddassir,Cranston Amy,Morton Miranda,Walker Jenn,Frame Sheelagh,Ng Wan-Fai,Buckley Christopher D,McInnes Iain B,Filer Andrew,Isaacs John D

Funder

Versus Arthritis

NIHR Newcastle Biomedical Research Centre

MRC

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference30 articles.

1. Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the Global Burden of Disease study 2017;Safiri;Ann Rheum Dis,2019

2. Novel treatment strategies in rheumatoid arthritis;Burmester;Lancet,2017

3. Distinct fibroblast subsets drive inflammation and damage in arthritis;Croft;Nature,2019

4. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity;Alessi;Exp Cell Res,1998

5. IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts;Perlman;J Immunol,2003

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation of cytotoxic aptamers specifically targeting fibroblast-like synoviocytes by CSCT-SELEX for treatment of rheumatoid arthritis;Annals of the Rheumatic Diseases;2024-09-04

2. Application of Injectable Hydrogels as Delivery Systems in Osteoarthritis and Rheumatoid Arthritis;British Journal of Hospital Medicine;2024-08-30

3. Phosphoproteomic profiling of early rheumatoid arthritis synovium reveals active signalling pathways and differentiates inflammatory pathotypes;Arthritis Research & Therapy;2024-06-12

4. Small-molecule targeting PKM2 provides a molecular basis of lactylation-dependent fibroblast-like synoviocytes proliferation inhibition against rheumatoid arthritis;European Journal of Pharmacology;2024-06

5. Molecular maps of synovial cells in inflammatory arthritis using an optimized synovial tissue dissociation protocol;iScience;2024-06